Gyre Therapeutics, Inc. (GYRE)
USD 7.49
(2.74%)
USD 7.49
(2.74%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | 113.45 Million | 794 Thousand | 7.33 Million | 20.94 Million | - | 6000.00 |
| Cost of Revenue | 4.63 Million | 798 Thousand | 7.38 Million | 9.16 Million | 43.85 Million | 21.47 Million |
| Gross Profit | 108.81 Million | -4000.00 | -42 Thousand | 11.78 Million | -43.85 Million | -21.46 Million |
| Operating Expenses | 89.6 Million | 30.4 Million | 87.85 Million | 69.15 Million | 57.27 Million | 33.82 Million |
| Selling, General and Administrative Expenses | 75.82 Million | 17.36 Million | 18.96 Million | 16.18 Million | 13.41 Million | 12.35 Million |
| Research and Development Expenses | 13.78 Million | 13.03 Million | 68.88 Million | 52.97 Million | 43.85 Million | 21.47 Million |
| Other Expenses | 86.44 Million | -517 Thousand | -78 Thousand | 568 Thousand | -46 Thousand | 1.65 Million |
| Cost and Expenses | 180.68 Million | 31.2 Million | 95.23 Million | 78.31 Million | 57.27 Million | 33.82 Million |
| Operating Income | -67.23 Million | -8.61 Million | -87.89 Million | -57.37 Million | -57.27 Million | -33.82 Million |
| Interest Expense | - | 717 Thousand | - | - | - | - |
| Income Tax Expense | 8.51 Million | 348 Thousand | -39 Thousand | -699 Thousand | -2.29 Million | 3.76 Million |
| Earnings before Tax | -76.96 Million | -7.89 Million | -87.93 Million | -56.24 Million | -55.17 Million | -30.05 Million |
| Net Income | -92.93 Million | 2.3 Million | -87.93 Million | -55.54 Million | -52.88 Million | -30.05 Million |
| Earnings Per Share Basic | -1.41 | 0.04 | -2.87 | -2.90 | -4.41 | -2.68 |
| Earnings Per Share Diluted | -1.41 | 0.03 | -2.87 | -2.90 | -4.41 | -2.68 |
| Weighted Average Shares Outstanding | 65.83 Million | 76.73 Million | 30.64 Million | 19.17 Million | 12 Million | 11.21 Million |
| Weighted Average Shares Outstanding (Diluted) | 65.83 Million | 75.68 Million | 30.64 Million | 19.17 Million | 12 Million | 11.21 Million |
| Gross Margin | 0.96 | -0.01 | -0.01 | 0.56 | - | -3578.00 |
| EBIT Margin | 0.18 | -65.68 | -11.94 | -2.74 | - | -5637.00 |
| Profit Margin | -0.82 | 2.90 | -11.98 | -2.65 | - | -5009.17 |
| EBITDA | 20.32 Million | 10.33 Million | -87.6 Million | -57.37 Million | -57.27 Million | -33.82 Million |
| Earnings Before Tax Margin | -0.59 | -10.85 | -11.98 | -2.74 | - | -5637.00 |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Revenue | 25.22 Million | 27.17 Million | 113.45 Million | 29.98 Million | 30.73 Million | 26.13 Million |
| Cost of Revenue | 770 Thousand | 979 Thousand | 4.63 Million | 1.24 Million | 1.27 Million | 318 Thousand |
| Gross Profit | 24.45 Million | 26.19 Million | 108.81 Million | 28.73 Million | 29.45 Million | 25.81 Million |
| Operating Expenses | 21.19 Million | 14.04 Million | 89.6 Million | 75.51 Million | 2.82 Million | 2.54 Million |
| Selling, General and Administrative Expenses | 17.83 Million | 15.94 Million | - | 21.22 Million | 2.4 Million | 2.22 Million |
| Research and Development Expenses | 3.35 Million | 2.18 Million | - | 46.78 Million | 415 Thousand | 318 Thousand |
| Other Expenses | -422 Thousand | -206 Thousand | -1.51 Million | - | - | 629 Thousand |
| Cost and Expenses | 21.96 Million | 15.01 Million | 94.23 Million | 76.76 Million | 2.82 Million | 2.54 Million |
| Operating Income | 3.26 Million | 8.07 Million | -67.23 Million | 2.26 Million | -1.62 Million | -2.54 Million |
| Interest Expense | - | - | - | - | - | - |
| Income Tax Expense | 1.49 Million | 2.54 Million | 8.51 Million | 2.2 Million | 2.26 Million | 2000.00 |
| Earnings before Tax | 6.03 Million | 12.48 Million | -76.96 Million | -46.25 Million | -1.57 Million | -2.47 Million |
| Net Income | 3.52 Million | 7.53 Million | -92.93 Million | -52.19 Million | -52.03 Million | 5.59 Million |
| Earnings Per Share Basic | 0.04 | 0.09 | - | -0.68 | -0.68 | 0.15 |
| Earnings Per Share Diluted | 0.03 | 0.07 | - | -0.68 | -0.68 | 0.15 |
| Weighted Average Shares Outstanding | 85.5 Million | 83.26 Million | 65.83 Million | 76.59 Million | 76.59 Million | 37.8 Million |
| Weighted Average Shares Outstanding (Diluted) | 104.32 Million | 102.59 Million | 65.83 Million | 76.59 Million | 76.59 Million | 37.8 Million |
| Gross Margin | 0.97 | 0.96 | 0.96 | 0.96 | 0.96 | 0.99 |
| EBIT Margin | 0.14 | 0.31 | - | 0.08 | -0.05 | -0.10 |
| Profit Margin | 0.14 | 0.28 | -0.82 | -1.74 | -1.69 | 0.21 |
| EBITDA | 3.5 Million | 8.34 Million | - | 2.45 Million | -1.62 Million | -2.54 Million |
| Earnings Before Tax Margin | 0.13 | 0.30 | -0.59 | 0.08 | -0.05 | -0.10 |
CBDHF
002329
IPHYF
BMRPF
MYOR
VQS